US5786464C1
(en)
*
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
US6247995B1
(en)
|
1996-02-06 |
2001-06-19 |
Bruce Bryan |
Bioluminescent novelty items
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
GB9611981D0
(en)
*
|
1996-06-07 |
1996-08-07 |
Zeneca Ltd |
Enhancement of gene expression
|
WO1997048370A2
(en)
*
|
1996-06-21 |
1997-12-24 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
US6416960B1
(en)
|
1996-08-08 |
2002-07-09 |
Prolume, Ltd. |
Detection and visualization of neoplastic tissues and other tissues
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
US6593135B2
(en)
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
US6114148C1
(en)
*
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
ATE290205T1
(de)
|
1996-12-12 |
2005-03-15 |
Prolume Ltd |
Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
|
JP2001512308A
(ja)
*
|
1997-02-07 |
2001-08-21 |
メルク エンド カンパニー インコーポレーテッド |
合成hiv gag遺伝子
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
US7105724B2
(en)
|
1997-04-04 |
2006-09-12 |
Board Of Regents Of University Of Nebraska |
Methods and materials for making and using transgenic dicamba-degrading organisms
|
CA2285676C
(en)
|
1997-04-04 |
2011-03-08 |
Donald P. Weeks |
Methods and materials for making and using transgenic dicamba-degrading organisms
|
AUPP807899A0
(en)
*
|
1999-01-08 |
1999-02-04 |
University Of Queensland, The |
Codon utilization
|
US6602677B1
(en)
*
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
CN1179048C
(zh)
*
|
1997-10-20 |
2004-12-08 |
Gtc生物治疗学公司 |
修饰的MSP-1核酸序列以及增加细胞系统中mRNA水平和蛋白质表达的方法
|
GB9803351D0
(en)
*
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
HU228267B1
(en)
|
1998-02-20 |
2013-02-28 |
Syngenta Ltd |
Method for producing hybrid seed, expression casettes usable in the method, and plant tissuses or plants containing them
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
US20090042283A1
(en)
*
|
1998-09-29 |
2009-02-12 |
Shire Human Genetic Therapies, Inc., A Delaware Corporation |
Optimized messenger rna
|
EP1010763A1
(en)
*
|
1998-12-11 |
2000-06-21 |
Institut Pasteur |
Enhanced expression of heterologous proteins in recombinant bacteria through reduced growth temperature and co-expression of rare tRNA's
|
US7935805B1
(en)
*
|
1998-12-31 |
2011-05-03 |
Novartis Vaccines & Diagnostics, Inc |
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
|
WO2000039302A2
(en)
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Improved expression of hiv polypeptides and production of virus-like particles
|
WO2000039304A2
(en)
*
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
AU2596600A
(en)
|
1998-12-31 |
2000-07-31 |
Chiron Corporation |
Modified hiv env polypeptides
|
CA2369119A1
(en)
|
1999-03-29 |
2000-05-25 |
Statens Serum Institut |
Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
|
US20050005310A1
(en)
*
|
1999-07-12 |
2005-01-06 |
Genentech, Inc. |
Expression vectors and methods
|
US6716614B1
(en)
*
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US20030096778A1
(en)
*
|
2002-06-13 |
2003-05-22 |
Shiver John W |
Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
|
US20040063653A1
(en)
*
|
2000-12-21 |
2004-04-01 |
Shiver John W. |
Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol
|
US6656706B2
(en)
*
|
1999-12-23 |
2003-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
|
CA2400642A1
(en)
*
|
2000-02-23 |
2001-08-30 |
Vertex Pharmaceuticals (San Diego) Llc |
Modified fluorescent proteins
|
US6502774B1
(en)
*
|
2000-03-08 |
2003-01-07 |
J + L Fiber Services, Inc. |
Refiner disk sensor and sensor refiner disk
|
WO2002008417A1
(fr)
*
|
2000-07-25 |
2002-01-31 |
Takeda Chemical Industries, Ltd. |
Procede de production d'une proteine de recombinaison
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
US7879540B1
(en)
*
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
AU2000268170A1
(en)
*
|
2000-09-04 |
2002-03-22 |
Hunan Royal Biotech |
A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation
|
US7122180B2
(en)
*
|
2000-10-23 |
2006-10-17 |
Children's Medical Center Corporation |
DNA vectors containing mutated HIV proviruses
|
AU2002232936A1
(en)
*
|
2000-10-30 |
2002-05-15 |
Lexicon Genetics Incorporated |
Human 7TM proteins and polynucleotides encoding the same
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
EP1832603B1
(de)
*
|
2001-06-05 |
2010-02-03 |
CureVac GmbH |
Stabilisierte mRNA mit erhöhtem G/C-Gehalt, enkodierend für ein bakterielles Antigen sowie deren Verwendung
|
JP3829252B2
(ja)
*
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
US6780974B2
(en)
*
|
2001-06-12 |
2004-08-24 |
Cellomics, Inc. |
Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
|
EP1578987A2
(en)
*
|
2001-08-03 |
2005-09-28 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
US6943001B2
(en)
*
|
2001-08-03 |
2005-09-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
CA2458995C
(en)
*
|
2001-08-31 |
2013-04-30 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
|
ES2329666T3
(es)
*
|
2001-12-19 |
2009-11-30 |
The University Of Chicago |
Proteinas fluorescentes de maduracion rapida y procedimientos de uso de las mismas.
|
EP1470148B1
(en)
|
2002-02-01 |
2012-07-18 |
Life Technologies Corporation |
Double-stranded oligonucleotides
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP1572902B1
(en)
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
BR0309391A
(pt)
|
2002-04-19 |
2005-10-25 |
Diversa Corp |
Fosfolipases, ácidos nucléicos codificando-as e métodos para preparar e usá-las
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
NZ537597A
(en)
|
2002-06-14 |
2008-07-31 |
Diversa Corp |
Xylanases, nucleic acids encoding them and methods for making and using them
|
EP1576140A4
(en)
*
|
2002-09-26 |
2007-08-08 |
Kosan Biosciences Inc |
ARTIFICIAL GENES
|
EP1578969B1
(en)
*
|
2002-11-08 |
2010-04-07 |
The University Of Queensland |
A method for optimising gene expression using synonymous codon optimisation
|
AU2003285844A1
(en)
|
2002-11-12 |
2004-06-03 |
Zakrytoe Aktsionernoe Obschestvo "Evrogen" |
Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same
|
CA2504595A1
(en)
*
|
2002-11-14 |
2004-06-03 |
Lynne Krummen |
Intron fusion construct and method of using for selecting high-expressing production cell lines
|
US7413874B2
(en)
*
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
ES2429338T3
(es)
*
|
2002-12-23 |
2013-11-14 |
Vical Incorporated |
Vacuna basada en polinucleótidos optimizados por codones contra infección por citomegalovirus humano
|
US7678893B2
(en)
|
2002-12-26 |
2010-03-16 |
Zakrytoe Aktsionernoe Obschestvo “Evrogen” |
Fluorescent proteins from Copepoda species and methods for using same
|
PL3023498T3
(pl)
|
2003-03-06 |
2019-05-31 |
Basf Enzymes Llc |
Amylazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i zastosowania
|
CA3007908A1
(en)
|
2003-03-07 |
2005-04-14 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
WO2004090099A2
(en)
|
2003-04-04 |
2004-10-21 |
Diversa Corporation |
Pectate lyases, nucleic acids encoding them and methods for making and using them
|
EP1622937A2
(en)
*
|
2003-05-05 |
2006-02-08 |
Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. |
Synthetic gene encoding human carcinoembryonic antigen and uses thereof
|
CN103484486B
(zh)
|
2003-07-02 |
2018-04-24 |
维莱尼姆公司 |
葡聚糖酶,编码它们的核酸以及制备和使用它们的方法
|
US7741089B2
(en)
|
2003-08-11 |
2010-06-22 |
Verenium Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
EP1732944B1
(en)
|
2004-04-07 |
2012-09-05 |
The University of Chicago |
Monomeric red fluorescent proteins
|
AU2005250477A1
(en)
*
|
2004-06-04 |
2005-12-15 |
Wyeth |
Enhancing protein expression
|
BRPI0510939A
(pt)
|
2004-06-16 |
2007-07-17 |
Diversa Corp |
composições e métodos para descoloração enzimática de clorofila
|
US7728118B2
(en)
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
WO2006049777A2
(en)
*
|
2004-09-30 |
2006-05-11 |
Trustees Of Dartmouth College |
Nucleic acid sequences encoding luciferase for expression in filamentous fungi
|
US7888489B2
(en)
|
2005-01-24 |
2011-02-15 |
Dsm Ip Assets B.V. |
Method for producing a compound of interest in a filamentous fungal cell
|
US20090038023A1
(en)
|
2005-03-10 |
2009-02-05 |
Verenium Corporation |
Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
|
KR101393679B1
(ko)
|
2005-03-15 |
2014-05-21 |
비피 코포레이션 노쓰 아메리카 인코포레이티드 |
셀룰라제, 이것을 암호화하는 핵산 및 이들을 제조 및사용하는 방법
|
DE602006017237D1
(en)
|
2005-04-05 |
2010-11-11 |
Allergan Inc |
Clostridientoxinaktivitätstests
|
EP1934605B1
(en)
*
|
2005-09-22 |
2014-03-26 |
Prosci Incorporated |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
RU2412250C2
(ru)
*
|
2005-11-04 |
2011-02-20 |
Закрытое акционерное общество "ЕВРОГЕН" |
Модифицированные зеленые флуоресцентные белки и способы их использования
|
US8563703B2
(en)
|
2006-01-25 |
2013-10-22 |
Evrogen IP Joint Stock Company |
Fluorescent proteins and methods for using same
|
EP1994149B1
(en)
|
2006-01-25 |
2010-09-29 |
Evrogen IP |
Novel fluorescent proteins and methods for using same
|
EP2216403A3
(en)
|
2006-02-02 |
2010-11-24 |
Verenium Corporation |
Esterases and related nucleic acids and methods
|
MY160772A
(en)
|
2006-02-10 |
2017-03-15 |
Verenium Corp |
Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
|
USRE45660E1
(en)
|
2006-02-14 |
2015-09-01 |
Bp Corporation North America Inc. |
Xylanases, nucleic acids encoding them and methods for making and using them
|
WO2007103389A2
(en)
|
2006-03-07 |
2007-09-13 |
Cargill, Incorporated |
Aldolases, nucleic acids encoding them and methods for making and using them
|
EP2385108B1
(en)
|
2006-03-07 |
2016-11-23 |
BASF Enzymes LLC |
Aldolases, nucleic acids encoding them and methods for making and using them
|
US7855326B2
(en)
|
2006-06-06 |
2010-12-21 |
Monsanto Technology Llc |
Methods for weed control using plants having dicamba-degrading enzymatic activity
|
CA2657975A1
(en)
|
2006-06-29 |
2008-01-03 |
Dsm Ip Assets B.V. |
A method for achieving improved polypeptide expression
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
CA2669453C
(en)
|
2006-08-04 |
2018-11-13 |
Verenium Corporation |
Glucanases, nucleic acids encoding them and methods for making and using them
|
HUE025544T2
(en)
|
2006-09-21 |
2016-02-29 |
Basf Enzymes Llc |
Phytases, nucleic acids and processes encoding them for their production and use
|
PL2057274T3
(pl)
|
2006-09-21 |
2014-05-30 |
Dsm Ip Assets Bv |
Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania
|
EP2053916A2
(en)
|
2006-10-16 |
2009-05-06 |
Monsanto Technology, LLC |
Methods and compositions for improving plant health
|
ES2734114T3
(es)
|
2006-12-21 |
2019-12-04 |
Basf Enzymes Llc |
Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
|
CN101652381B
(zh)
|
2007-01-30 |
2014-04-09 |
维莱尼姆公司 |
用于处理木质纤维素的酶、编码它们的核酸及其制备和应用方法
|
US7838729B2
(en)
|
2007-02-26 |
2010-11-23 |
Monsanto Technology Llc |
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
|
US9043994B2
(en)
*
|
2007-03-13 |
2015-06-02 |
Massachusetts Institute Of Technology |
Cre-lox based gene knockdown constructs and methods of use thereof
|
US20080248511A1
(en)
*
|
2007-03-26 |
2008-10-09 |
Promega Corporation |
Methods to quench light from optical reactions
|
JP5744518B2
(ja)
|
2007-10-03 |
2015-07-08 |
ビーピー・コーポレーション・ノース・アメリカ・インコーポレーテッド |
キシラナーゼ、キシラナーゼをコードする核酸並びにそれらを製造及び使用する方法
|
WO2009049351A1
(en)
*
|
2007-10-15 |
2009-04-23 |
The University Of Queensland |
Construct system and uses therefor
|
WO2009059305A2
(en)
*
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
EP2238261B1
(en)
|
2008-01-03 |
2013-12-04 |
Verenium Corporation |
Isomerases, nucleic acids encoding them and methods for making and using them
|
US8709772B2
(en)
|
2008-01-03 |
2014-04-29 |
Verenium Corporation |
Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
|
US8126653B2
(en)
*
|
2008-07-31 |
2012-02-28 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
US7561973B1
(en)
|
2008-07-31 |
2009-07-14 |
Dna Twopointo, Inc. |
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
US8401798B2
(en)
*
|
2008-06-06 |
2013-03-19 |
Dna Twopointo, Inc. |
Systems and methods for constructing frequency lookup tables for expression systems
|
US7561972B1
(en)
|
2008-06-06 |
2009-07-14 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
JP5304275B2
(ja)
*
|
2009-01-29 |
2013-10-02 |
Jnc株式会社 |
アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
|
AU2010249500B2
(en)
|
2009-05-21 |
2016-03-24 |
Basf Enzymes Llc |
Phytases, nucleic acids encoding them and methods for making and using them
|
CN102648285A
(zh)
|
2009-08-06 |
2012-08-22 |
Cmc依科斯生技制品公司 |
用于改进重组蛋白表达的方法
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
BR112012018914A2
(pt)
|
2010-01-28 |
2017-07-25 |
Glaxo Group Ltd |
"anticorpo humanizado, proteína de ligação de antígeno, molécula de ácido nucleico, vetor de expressão, célula hospedeira recombinante, proteína de ligação de anticorpo ou de antígeno, métodos para a produção de uma proteína de ligação de antígeno e para tratar um sujeito afetado por uma doença autoimune ou inflamatória, e, composição farmacêutica."
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
CA2805035A1
(en)
|
2010-07-22 |
2012-01-26 |
Glaxosmithkline Biologicals S.A. |
Novel antigen binding proteins
|
WO2013156443A1
(en)
|
2012-04-17 |
2013-10-24 |
F. Hoffmann-La Roche Ag |
Method for the expression of polypeptides using modified nucleic acids
|
EP2844290A4
(en)
|
2012-05-01 |
2015-12-16 |
Glaxosmithkline Llc |
NOVEL ANTIBODIES
|
EP2850106B1
(en)
|
2012-05-18 |
2022-03-23 |
Aptevo Research and Development LLC |
Bispecific scfv immunofusion (bif) binding to cd123 and cd3
|
WO2013189878A1
(en)
|
2012-06-19 |
2013-12-27 |
Dsm Ip Assets B.V. |
Promoters for expressing a gene in a cell
|
RS62189B1
(sr)
|
2013-08-26 |
2021-08-31 |
Biontech Research And Development Inc |
Nukleinske kiseline koje kodiraju humana antitela na sijalil-luis a
|
WO2015187811A2
(en)
|
2014-06-04 |
2015-12-10 |
MabVax Therapeutics, Inc. |
Human monoclonal antibodies to ganglioside gd2
|
WO2016059602A2
(en)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Methods of treating cancer and related compositions
|
WO2016186948A1
(en)
|
2015-05-15 |
2016-11-24 |
Albert Einstein College Of Medicine, Inc. |
Gfp-derived fusion tags for protein expression
|
AU2016321298A1
(en)
|
2015-09-09 |
2018-03-29 |
The Trustees Of Columbia University In The City Of New York |
Reduction of ER-MAM localized APP-C99 and methods of treating Alzheimer's Disease
|
EP3694889A1
(en)
|
2017-10-13 |
2020-08-19 |
Boehringer Ingelheim International GmbH |
Human antibodies to thomsen-nouvelle (tn) antigen
|
RU2730038C2
(ru)
|
2018-06-28 |
2020-08-14 |
Общество с ограниченной ответственностью "ПЛАНТА" |
Ферменты биосинтеза люциферина и их применение
|
BR112021025806A2
(pt)
|
2019-06-28 |
2022-02-08 |
Hoffmann La Roche |
Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamster
|
US20230312743A1
(en)
|
2021-11-19 |
2023-10-05 |
Mirobio Limited |
Engineered pd-1 antibodies and uses thereof
|
US20230416361A1
(en)
|
2022-04-06 |
2023-12-28 |
Mirobio Limited |
Engineered cd200r antibodies and uses thereof
|